Table 5.
Compound NO. | Classification | The major targets | Activity | References |
---|---|---|---|---|
64 | Piperine derivatives | Inhibiting apoptotic cell death induced by IBO Inhibited the interaction between Keap1 and Nrf2 |
_ | 85 |
65 | Inhibits the increase of Bax/Bcl2 ratio protects hippocampal neurons Inhibits the activation of NLRP3 inflammatory bodies in hippocampus Reduces Aβ1-42 Induced neurotoxicity in SH-SY5Y cells |
_ | 90 | |
66 | Harmine derivatives | Inhibits GSK-3β and DYRK1A, Inhibits oka induced tau hyperphosphorylation in SH-SY5Y cells, |
IC50 (GSK-3β) = 71 nM IC50 (DYRK1A) = 103 nM |
91 |
67 | AChE inhibitory activity BChE inhibitory activity Inhibits GSK-3β |
IC50 (hAChE) = 0.27 µM IC50 (hBChE) = 20.82 µM IC50 (GSK-3β) = 6.78 µM |
92 | |
68 | Oxymatrine derivatives | Protect PC12 cells from Aβ induced damage Inhibition of LPS induced NO |
_ | 93 |
69 | ||||
70 |